ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cancer

Walmart, Home Depot Adopt Health Insurer Tactic in Drug Copay Battle

Caroline Humer and Michael Erman  |  November 14, 2018

NEW YORK (Reuters)—Walmart and Home Depot, two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications. Large U.S. companies have started tightly managing how employees and their family members use these popular discount, or copay, cards…

Filed under:Uncategorized Tagged with:copay accumulatorscopay cardscopay maximizersCVS Healthdiscount cardsExpress Scripts Holding Cohealth insurance strategyHome DepotWalmart

Genetic Discoveries Pave New Pathways to the Origins of Rheumatic Diseases

Carina Stanton  |  November 5, 2018

New research has provided a never-before-seen view of the genetic activity that may be used to map the polygenic nature of common rheumatic diseases. Two recent studies have employed distinct approaches to identify the non-coding gene variants, digging deep into human genetic data to uncover the mechanism of rheumatic diseases…

Filed under:Conditions Tagged with:genegeneticgenomeGWASRheumatic Disease

FDA Rejects Novartis Bid to Repurpose Inflammation Drug for Heart Attacks

John Miller  |  October 22, 2018

ZURICH (Reuters)—The U.S. Food and Drug Administration (FDA) has rejected Novartis’s bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group of heart attack survivors, according to the Swiss drugmaker. The company received an FDA letter turning down its bid to make canakinumab a targeted therapy for those…

Filed under:Drug Updates Tagged with:canakinumabcardiovascularFamilial Mediterranean feverFDAheartNovartisU.S. Food and Drug Administration (FDA)

Fighting Lupus Among Latinas

From the College  |  October 18, 2018

Systemic lupus erythematosus (SLE) is more prevalent among Hispanic women than white women, according to two recent studies published in Arthritis & Rheumatology.1,2 However, Latinas often lack awareness of lupus, which can contribute to delays in diagnosis and treatment, and lead to worse outcomes. “One of the challenges is reaching out to the Latino community,…

Filed under:Education & TrainingFrom the CollegeSystemic Lupus Erythematosus Tagged with:Collaboration InitiativesCollaborative Initiatives Special Committee (COIN)

Big Data May Shift Reference Ranges for Some Lab Tests

Susan Bernstein  |  October 18, 2018

How will big data mined from huge sample sizes in research cohorts, electronic health records, personal health data (e.g., heart rates from Fitbits) and insurance claim data sets change the way physicians interpret something as simple as complete blood count (CBC) test results for individual patients? According to the authors of a paper in the…

Filed under:Technology Tagged with:big datalab test

Nivolumab-Induced Arthritis

Catherine Strahle, DO, Nathalie E. Chalhoub, MD, & Avis Ware, MD  |  October 18, 2018

Immune checkpoint inhibitors (ICIs) are increasingly used to treat a variety of malignancies, leading to better cancer treatment outcomes and patient survival. However, the emergence of autoimmunity has been a major adverse event resulting from ICI use. Below, we describe a patient who experienced a flare of preexisting psoriasis and new-onset severe psoriatic arthritis after…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Cancercase reportimmune checkpoint inhibitor (ICI)nivolumabpsoriatic arthritisskin psoriasis

Study Reveals Lupus Is a Leading Cause of Death in U.S. Women

Kimberly J. Retzlaff  |  October 18, 2018

Systemic lupus erythematosus (SLE) is a leading cause of death among young women, according to an August 2018 study in Arthritis & Rheumatology.1 To help determine where SLE ranks among causes of death, Eric Y. Yen, MD, and Ram Raj Singh, MD, conducted a population-based study using nationwide mortality counts for all female residents of…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:death rateGendermortality rateRheumatology Research Foundation

A Historical Look at the Characterization of Lupus as a Systemic Disease

Ruth Jessen Hickman, MD  |  October 18, 2018

The disease called systemic lupus erythematosus (SLE) went through many different stages of classification before reaching the modern criteria reflecting our current understanding of its pathogenesis. In 1872, the Viennese dermatologist Moriz Kaposi, MD, published a paper, “New Contributions to Knowledge of Lupus Erythematosus,” which provided a significant leap forward in the characterization of this…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Classification CriteriaDr. Moriz KaposiHistoryLost & Found

The Case of a 13-Year-Old Girl with Life-Threatening Lupus Onset

Charles Radis, DO  |  October 18, 2018

I glanced up from Amanda Wolf’s chart as the emergency department nurse, followed by the lab technician (tech), followed by the electrocardiogram (ECG) tech flowed into cubicle No. 5. John Benner, MD, pulled up a chair to review the case with me at the nursing station. “Here’s what we’ve got. Thirteen-year-old girl with a one-week…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:cyclophosphamidekidney failurePericarditisSteroids

Social Media May Reduce Depression Risk for Older People with Pain

Cheryl Platzman Weinstock  |  October 10, 2018

(Reuters Health)—Online socializing may weaken the tie between pain and depression for older people, a U.S. study suggests. People in chronic pain are at risk of depression to start with. When pain makes them stay home more, interacting with friends and family less, it only adds to this risk, the researchers write in the Journals…

Filed under:ConditionsPain SyndromesTechnology Tagged with:Chronic painDepressiononline socializingSocial Media

  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 86
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences